Literature DB >> 1414845

AIDS-related CNS cryptococcosis: radiologic-pathologic correlation.

V P Mathews1, P L Alo, J D Glass, A J Kumar, J C McArthur.   

Abstract

PURPOSE: This study evaluates the effectiveness of cranial CT and MR in detecting autopsy findings of AIDS-related CNS cryptococcosis.
METHODS: Final imaging studies compared with pathology were CT in eight patients (five with contrast) and MR in five patients (all with Gd-DTPA).
RESULTS: Neither modality effectively identified cryptococcal meningitis. Punctate hyperintensities were seen in all patients with MR and corresponded pathologically to both perivascular spaces dilated by cryptococcal infection and cryptococcomas. Pathologically, cryptococcomas were more common than dilated perivascular spaces. MR detected more cryptococcomas than did CT, but both modalities underestimated the number of lesions seen at autopsy. Contrast enhancement of cryptococcomas and cryptococcal meningitis was uncommon.
CONCLUSIONS: CNS cryptococcosis was more effectively demonstrated by MR than by CT, but both modalities underestimated the pathologic extent of the disease. Cryptococcal lesion contrast enhancement was unusual possibly because of the immunocompromised state of our patients and the unique characteristics of the organism itself.

Entities:  

Mesh:

Year:  1992        PMID: 1414845      PMCID: PMC8335225     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  16 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Spinal cord involvement in primary angiitis of the central nervous system: a report of two cases.

Authors:  A Campi; G Benndorf; V Martinelli; M R Terreni; G Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 3.  Magnetic resonance spectroscopy findings of pyogenic, tuberculous, and Cryptococcus intracranial abscesses.

Authors:  Abdurrahim Dusak; Bahattin Hakyemez; Hasan Kocaeli; Ahmet Bekar
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

4.  Magnetic resonance imaging study of cryptococcal neuroradiological lesions in HIV-negative cryptococcal meningitis.

Authors:  Y Zhong; Z Zhou; X Fang; F Peng; W Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-28       Impact factor: 3.267

5.  Calcified cerebral cryptococcal granuloma.

Authors:  Jing-Qi Zhu; Xiao-Feng Tao; Wei-Qun Bao; Nan-Xin Hao; Xiang-Ru Wu
Journal:  Indian J Pediatr       Date:  2012-04-28       Impact factor: 1.967

Review 6.  Management of Cryptococcus gattii meningoencephalitis.

Authors:  Carlos Franco-Paredes; Tanea Womack; Teri Bohlmeyer; Brenda Sellers; Allison Hays; Kalpesh Patel; Jairo Lizarazo; Shawn R Lockhart; Wajid Siddiqui; Kieren A Marr
Journal:  Lancet Infect Dis       Date:  2014-11-26       Impact factor: 25.071

7.  An Uncommon Presentation of Cryptococcal Meningoencephalitis.

Authors:  Isabel Freitas; Tatiana Salazar; Pedro Rodrigues; Maria Vilela; Augusto Duarte
Journal:  Cureus       Date:  2022-02-07

8.  MRI of a pituitary cryptococcoma simulating an adenoma.

Authors:  Y Q Yu; X X Jiang; Y J Gao
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

Review 9.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

10.  Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

Authors:  Caroline Charlier; Françoise Dromer; Christophe Lévêque; Loïc Chartier; Yves-Sébastien Cordoliani; Arnaud Fontanet; Odile Launay; Olivier Lortholary
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.